1Appelbaum FR,Gundacker H,Head DR,et al.Age and acute myeloid leukemia[J].Blood,2006,107(9):3481-3485.
2Burnett AK,Hills RK,Milligan DW,et al.Attempts to optimize induction and consolidation treatment in acute myeloid leukemia:results of the MRC AML12 trial[J].J Clin Oncol,2010,28(4):586-595.
3Burnett AK,Milligan D,Goldstone A,et al.The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome:the results of the LRF AML14 trial[J].Br J Haematol,2009,145(3):318-332.
4Sorror ML,Giralt S,Sandmaier BM,et al.Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission:combined FHCRC and MDACC experiences[J].Blood,2007,110(13):4606-4613.
5Martin G,Barragan E,Bolufer P,et al.Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta/MYH11 rearrangement[J].Haematologica,2000,85(7):699-703.
6Nguyen S,Leblanc T,Fenaux P,et al.A white blood cell index as the main prognostic factor in t(8; 21) acute myeloid leukemia (AML):a survey of 161 cases from the French AML Intergroup[J].Blood,2002,99(10):3517-3523.
7Burnett AK,Grimwade D,Solomon E,et al.Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid:result of the Randomized MRC Trial[J].Blood,1999,93(12):4131-4143.
8Swerdlow SH,Campo E,Harris NL,et al.WHO classification of tumours of haematopoietic and lymphoid tissues[M].4th ed.Lyon:IARC,2008.
9Larson RA.Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?[J]Best Pract Res Clin Haematol,2007,20(1):29-37.
10Mrózek K,Heerema NA,Bloomfield CD.Cytogenetics in acute leukemia[J].Blood Rev,2004,18(2):115-136.
4Bullinger L, Ehrich M, Dhner K, et al. Quantitative DNA methylation predicts survival in adult acute myeloid leukemia [J]. Blood,2010,115(3) :636-642.
5Burnett AK, Hills RK, Milligan DW, et al. Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML 12 trial[J]. J Clin Oncol, 2010,28 (4) :586-595.
6Chase AjReiter A,Burci L,et al.Fusion of ETV6 to the caudal-related homeobox gene CDX2 in acute myeloid leukemia with the t(12;13)(p13; q12)[J].Blood,1999,93(3):1025-1031.
7Scholl C,Bansal D,D'hner K,et al.The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis[J].J Clin Invest,2007,117(4):1037-1048.
